Science

Profiling the Global Warming Skeptics

The core of the small global network of global warming skeptics are once more gathering at a conference organized by the Heartland Institute, a corporate and foundation funded think tank based in Chicago.

Science Needs Permission?

"Biotechnology companies are keeping university scientists from fully researching the effectiveness and environmental impact of the industry’s genetically modified crops, according to an unusual complaint issued by a group of those scientists," reports Andrew Pollack.

The Higher Cost of Biofuels

A new study found that there is a higher health cost associated with corn-based biofuels than with traditional energy forms.

Support for Whistleblowers

The U.S. House of Representatives voted to strengthen protections for whistleblowers, especially those that work for the Transportation Security Administration (TSA) and in other areas of national security.

This Is Your University, on Drugs

In 2002, an independent study on hormone replacement therapy was halted, because the drugs were strongly linked to an "increased risk for breast cancer, heart disease, stroke and blood clots" in women. The same year, the University of Wisconsin-Madison began offering an online course, "funded entirely by a $12 million grant from Wyeth Pharmaceuticals," that "promoted hormone therapy, touted its benefits and downplayed its risks." Wyeth makes two hormone therapy drugs, Prempro and Premarin.

How Big Tobacco Deals with Adverse Research -- and Researchers

A case study in the January issue of the American Journal of Public Health shows the extent to which the tobacco industry works to derail research -- and researchers -- that could adversely affect it.

How Wyeth Bought Science that Sells

According to internal documents, the pharmaceutical company Wyeth "paid ghostwriters to produce medical journal articles favorable to its female hormone replacement therapy Prempro." As early as 1997, Wyeth paid the "medical writing firm" DesignWrite to publish favorable journal articles about Prempro under academics' names.

Pharma See, Pharma Sue

The Canadian Association of University Teachers has strongly condemned a new lawsuit by the Apotex pharmaceutical company against Dr. Nancy Olivieri. As a liver specialist at the University of Toronto, Olivieri first came under attack from Apotex in 1996 when she notified her patients that she had detected toxic side effects while conducting an Apotex-sponsored study of the company's drug, deferiphone.

Drugmakers' Dollars, Doctors' Disclosure Disorders

Doctors Frederick Goodwin and Joseph Biederman are counterattacking in an effort to defend their reputations following disclosures that they took millions of dolla

Participatory Project: What's Happening at the Climate Change Negotiations?

As scientific warnings about the potential risks of climate change intensify, governments realize they need to at least be seen as responsive to global warming concerns. But, behind the scenes, many of the world's richest countries are dragging their feet.

Syndicate content